CABA
Price
$2.74
Change
+$0.31 (+12.76%)
Updated
Jan 17 closing price
Capitalization
133.92M
54 days until earnings call
CDTX
Price
$21.70
Change
+$0.45 (+2.12%)
Updated
Jan 17 closing price
Capitalization
237.51M
Ad is loading...

CABA vs CDTX

Header iconCABA vs CDTX Comparison
Open Charts CABA vs CDTXBanner chart's image
Cabaletta Bio
Price$2.74
Change+$0.31 (+12.76%)
Volume$3.04M
Capitalization133.92M
Cidara Therapeutics
Price$21.70
Change+$0.45 (+2.12%)
Volume$229.23K
Capitalization237.51M
CABA vs CDTX Comparison Chart
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. CDTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and CDTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CABA: $2.74 vs. CDTX: $21.70)
Brand notoriety: CABA and CDTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 97% vs. CDTX: 231%
Market capitalization -- CABA: $133.92M vs. CDTX: $237.51M
CABA [@Biotechnology] is valued at $133.92M. CDTX’s [@Biotechnology] market capitalization is $237.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileCDTX’s FA Score has 1 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • CDTX’s FA Score: 1 green, 4 red.
According to our system of comparison, CDTX is a better buy in the long-term than CABA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 2 TA indicator(s) are bullish while CDTX’s TA Score has 3 bullish TA indicator(s).

  • CABA’s TA Score: 2 bullish, 4 bearish.
  • CDTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CDTX is a better buy in the short-term than CABA.

Price Growth

CABA (@Biotechnology) experienced а +32.05% price change this week, while CDTX (@Biotechnology) price change was -9.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

CABA is expected to report earnings on May 14, 2025.

CDTX is expected to report earnings on Aug 13, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($238M) has a higher market cap than CABA($134M). CABA YTD gains are higher at: 20.705 vs. CDTX (-19.271). CABA has higher annual earnings (EBITDA): -112.92M vs. CDTX (-127.83M). CABA has more cash in the bank: 183M vs. CDTX (127M). CDTX has less debt than CABA: CDTX (3.94M) vs CABA (15.2M). CDTX has higher revenues than CABA: CDTX (44.7M) vs CABA (0).
CABACDTXCABA / CDTX
Capitalization134M238M56%
EBITDA-112.92M-127.83M88%
Gain YTD20.705-19.271-107%
P/E RatioN/AN/A-
Revenue044.7M-
Total Cash183M127M144%
Total Debt15.2M3.94M385%
FUNDAMENTALS RATINGS
CDTX: Fundamental Ratings
CDTX
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABACDTX
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 11 days ago
86%
Momentum
ODDS (%)
Bearish Trend 11 days ago
86%
Bullish Trend 11 days ago
85%
MACD
ODDS (%)
Bullish Trend 11 days ago
84%
Bearish Trend 11 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
86%
Bearish Trend 11 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
88%
Bullish Trend 11 days ago
82%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
78%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
84%
View a ticker or compare two or three
Ad is loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLEAX14.700.09
+0.62%
GS Energy Infrastructure Fd A Shares
HFQDX6.140.03
+0.49%
Janus Henderson Global Equity Income D
NMVLX12.410.03
+0.24%
Nuance Mid Cap Value Institutional
MRJSX10.010.01
+0.10%
Morgan Stanley Multi-Asset Real ReturnR6
ALGAX18.86N/A
N/A
Alger International Opportunities A

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with PLRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+12.76%
PLRX - CABA
41%
Loosely correlated
-3.36%
ARWR - CABA
41%
Loosely correlated
+2.84%
ALLO - CABA
41%
Loosely correlated
-1.09%
CRSP - CABA
39%
Loosely correlated
+0.57%
IMNM - CABA
39%
Loosely correlated
+1.32%
More

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
+2.12%
BPTSY - CDTX
92%
Closely correlated
N/A
IVVD - CDTX
36%
Loosely correlated
-7.49%
CPRX - CDTX
35%
Loosely correlated
+0.53%
CABA - CDTX
33%
Poorly correlated
+12.76%
TRAW - CDTX
30%
Poorly correlated
-10.09%
More